Osteoporosis International

, Volume 26, Issue 2, pp 449–458 | Cite as

Low bone mineral density and fractures in stages 3–5 CKD: an updated systematic review and meta-analysis

  • R. C. Bucur
  • D. D. Panjwani
  • L. Turner
  • T. Rader
  • S. L. West
  • S. A. Jamal
Original Article



The utility of bone mineral density (BMD) testing in chronic kidney disease (CKD) is not known. We performed a meta-analysis of studies reporting on BMD and fracture in CKD. All but one study was cross-sectional. BMD was lower in those with CKD and fractures compared to those without fractures.


CKD is associated with an increased risk of fracture. The utility of dual energy X-ray absorptiometry (DXA) to assess fracture risk in CKD is unknown.


We performed an updated meta-analysis and systematic review of published studies that reported on the association between DXA and fracture (morphometric spine or clinical nonspine) in predialysis and dialysis CKD. We identified 2,894 potential publications, retrieved 292 for detailed review, and included 13. All but one study was cross-sectional and three reported on the ability of DXA to discriminate fracture status in predialysis CKD. Results were pooled using a random effects model and statistical heterogeneity was assessed using the I 2 statistic.


BMD was statistically significantly lower at the femoral neck, lumbar spine, the 1/3 and ultradistal radius in subjects with fractures compared to those without regardless of dialysis status. For example, femoral neck BMD was 0.06 g/cm2 lower in dialysis subjects and 0.102 g/cm2 lower in predialysis subjects with fractures compared to those without. Lumbar spine BMD was 0.05 g/cm2 lower in dialysis subjects and 0.108 g/cm2 lower in predialysis subjects with fractures compared to those without. Our meta-analysis was limited to studies with small numbers of subjects and even smaller numbers of fractures. All of the studies were observational and only one was prospective. There was statistical heterogeneity at the lumbar spine, 1/3 and ultradistal radius.


Our findings suggest that BMD can discriminate fracture status in predialysis and dialysis CKD. Larger, prospective studies are needed.


Bone mineral density Chronic kidney disease Dialysis Fractures Predialysis 



The authors would like to thank Dr. Pablo Urena for provision of his raw data. Dr. Jamal’s research is funded in part by the Canadian Institute of Health Research (CIHR).

Conflicts of interest

Roxana C. Bucur, Dilshaan D. Panjwani, Lucy Turner, Tamara Rader, Sarah L. West, and Sophie A. Jamal declare that they have no conflict of interest.

Supplementary material

198_2014_2813_MOESM1_ESM.docx (16 kb)
ESM 1 (DOCX 16 kb)
198_2014_2813_MOESM2_ESM.docx (14 kb)
ESM 2 (DOCX 14 kb)
198_2014_2813_MOESM3_ESM.docx (18 kb)
ESM 3 (DOCX 18 kb)


  1. 1.
    Ensrud KE, Lui LY, Taylor BC, Ishani A, Shlipak MG, Stone KL, Cauley JA, Jamal SA, Antoniucci DM, Cummings SR (2007) Renal function and risk of hip and vertebral fractures in older women. Arch Intern Med 167:133–139PubMedCrossRefGoogle Scholar
  2. 2.
    Alem AM, Sherrard DJ, Gillen DL, Weiss NS, Beresford SA, Heckbert SR, Wong C, Stehman-Breen C (2000) Increased risk of hip fracture among patients with end-stage renal disease. Kidney Int 58:396–399PubMedCrossRefGoogle Scholar
  3. 3.
    Cummings SR, Black D (1995) Bone mass measurements and risk of fracture in Caucasian women: a review of findings from prospective studies. Am J Med 98:24S–28SPubMedCrossRefGoogle Scholar
  4. 4.
    WHO (2008) FRAX WHO fracture risk asssessment tool. World Health Organization, Geneva.Google Scholar
  5. 5.
    Parfitt AM (1998) A structural approach to renal bone disease. J Bone Miner Res 13:1213–1220PubMedCrossRefGoogle Scholar
  6. 6.
    Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Work Group (2009) KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD). Kidney Int Suppl S1–S130Google Scholar
  7. 7.
    Jamal SA, Hayden JA, Beyene J (2007) Low bone mineral density and fractures in long-term hemodialysis patients: a meta-analysis. Am J Kidney Dis 49:674–681PubMedCrossRefGoogle Scholar
  8. 8.
    Moher D, Liberati A, Tetzlaff J, Altman DG (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ 339:b2535PubMedCentralPubMedCrossRefGoogle Scholar
  9. 9.
    World Health Organization (1994) Assessment of osteoporotic fracture risk and its role in screening for postmenopausal osteoporosis. WHO Technical Series GenevaGoogle Scholar
  10. 10.
    Furlan AD, Pennick V, Bombardier C, van Tulder M (2009) 2009 updated method guidelines for systematic reviews in the Cochrane Back Review Group. Spine (Phila Pa 1976) 34:1929–1941CrossRefGoogle Scholar
  11. 11.
    Berlin JA (1997) Does blinding of readers affect the results of meta-analyses? University of Pennsylvania Meta-analysis Blinding Study Group. Lancet 350:185–186PubMedCrossRefGoogle Scholar
  12. 12.
    Wells GA, Shea B, O’Connell D, Peterson J, Welch V, Losos M, Tugwell P The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Accessed 18 Nov 2013
  13. 13.
    Herzog R, Alvarez-Pasquin MJ, Diaz C, Del Barrio JL, Estrada JM, Gil A (2013) Are healthcare workers’ intentions to vaccinate related to their knowledge, beliefs and attitudes? A systematic review. BMC Public Health 13:154. doi: 10.1186/1471-2458-13-154 PubMedCentralPubMedCrossRefGoogle Scholar
  14. 14.
    DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7:177–188PubMedCrossRefGoogle Scholar
  15. 15.
    Higgins J (2009) Cochrane handbook for systematic reviews of interventions. Version 5.0.2: The Cochrane Collaboration. GS edsGoogle Scholar
  16. 16.
    Cummings SR, Nevitt MC, Browner WS, Stone K, Fox KM, Ensrud KE, Cauley J, Black D, Vogt TM (1995) Risk factors for hip fracture in white women. Study of Osteoporotic Fractures Research Group. N Engl J Med 332:767–773PubMedCrossRefGoogle Scholar
  17. 17.
    Jamal SA, Gilbert J, Gordon C, Bauer DC (2006) Cortical PQCT measures are associated with fractures in dialysis patients. J Bone Miner Res 21:543–548PubMedCrossRefGoogle Scholar
  18. 18.
    Nickolas TL, Cremers S, Zhang A, Thomas V, Stein E, Cohen A, Chauncey R, Nikkel L, Yin MT, Liu XS, Boutroy S, Staron RB, Leonard MB, McMahon DJ, Dworakowski E, Shane E (2011) Discriminants of prevalent fractures in chronic kidney disease. J Am Soc Nephrol 22:1560–1572PubMedCentralPubMedCrossRefGoogle Scholar
  19. 19.
    Nickolas TL, Stein E, Cohen A, Thomas V, Staron RB, McMahon DJ, Leonard MB, Shane E (2010) Bone mass and microarchitecture in CKD patients with fracture. J Am Soc Nephrol 21:1371–1380PubMedCentralPubMedCrossRefGoogle Scholar
  20. 20.
    Ambrus C, Almasi C, Berta K, Deak G, Marton A, Molnar MZ, Nemeth Z, Horvath C, Lakatos P, Szathmari M, Mucsi I (2011) Vitamin D insufficiency and bone fractures in patients on maintenance hemodialysis. Int Urol Nephrol 43:475–482PubMedCrossRefGoogle Scholar
  21. 21.
    Cejka D, Patsch JM, Weber M, Diarra D, Riegersperger M, Kikic Z, Krestan C, Schueller-Weidekamm C, Kainberger F, Haas M (2011) Bone microarchitecture in hemodialysis patients assessed by HR-pQCT. Clin J Am Soc Nephrol 6:2264–2271PubMedCentralPubMedCrossRefGoogle Scholar
  22. 22.
    Iimori S, Mori Y, Akita W, Kuyama T, Takada S, Asai T, Kuwahara M, Sasaki S, Tsukamoto Y (2011) Diagnostic usefulness of bone mineral density and biochemical markers of bone turnover in predicting fracture in CKD stage 5D patients—a single-center cohort study. Nephrol Dial Transplant 27:345–351PubMedCrossRefGoogle Scholar
  23. 23.
    Jamal SA, Cheung AM, West SL, Lok CE (2012) Bone mineral density by DXA and HR pQCT can discriminate fracture status in men and women with stages 3 to 5 chronic kidney disease. Osteoporos Int 23:2805–2813PubMedCrossRefGoogle Scholar
  24. 24.
    Yamaguchi T, Kanno E, Tsubota J, Shiomi T, Nakai M, Hattori S (1996) Retrospective study on the usefulness of radius and lumbar bone density in the separation of hemodialysis patients with fractures from those without fractures. Bone 19:549–555PubMedCrossRefGoogle Scholar
  25. 25.
    Fontaine MA, Albert A, Dubois B, Saint-Remy A, Rorive G (2000) Fracture and bone mineral density in hemodialysis patients. Clin Nephrol 54:218–226PubMedGoogle Scholar
  26. 26.
    Jamal SA, Chase C, Goh YI, Richardson R, Hawker GA (2002) Bone density and heel ultrasound testing do not identify patients with dialysis-dependent renal failure who have had fractures. Am J Kidney Dis 39:843–849PubMedCrossRefGoogle Scholar
  27. 27.
    Kaji H, Suzuki M, Yano S, Sugimoto T, Chihara K, Hattori S, Sekita K (2002) Risk factors for hip fracture in hemodialysis patients. Am J Nephrol 22:325–331PubMedCrossRefGoogle Scholar
  28. 28.
    Urena P, Bernard-Poenaru O, Ostertag A, Baudoin C, Cohen-Solal M, Cantor T, de Vernejoul MC (2003) Bone mineral density, biochemical markers and skeletal fractures in haemodialysis patients. Nephrol Dial Transplant 18:2325–2331PubMedCrossRefGoogle Scholar
  29. 29.
    Inaba M, Okuno S, Kumeda Y, Yamakawa T, Ishimura E, Nishizawa Y (2005) Increased incidence of vertebral fracture in older female hemodialyzed patients with type 2 diabetes mellitus. Calcif Tissue Int 76:256–260PubMedCrossRefGoogle Scholar
  30. 30.
    (1993) Consensus development conference: diagnosis, prophylaxis, and treatment of osteoporosis. Am J Med 94:646–650Google Scholar
  31. 31.
    Brown JP, Josse RG (2002) 2002 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada. CMAJ 167:S1–S34PubMedCentralPubMedGoogle Scholar
  32. 32.
    Cummings SR, Kelsey JL, Nevitt MC, O’Dowd KJ (1985) Epidemiology of osteoporosis and osteoporotic fracture. Epidemiol Rev 7:178–208PubMedGoogle Scholar
  33. 33.
    Duan Y, De Luca V, Seeman E (1999) Parathyroid hormone deficiency and excess: similar effects on trabecular bone but differing effects on cortical bone. J Clin Endocrinol Metab 84:718–722PubMedCrossRefGoogle Scholar
  34. 34.
    Jamal SA, Bauer DC, Ensrud KE, Cauley JA, Hochberg M, Ishani A, Cummings SR (2007) Alendronate treatment in women with normal to severely impaired renal function: an analysis of the fracture intervention trial. J Bone Miner Res 22:503–508PubMedCrossRefGoogle Scholar
  35. 35.
    Miller PD, Roux C, Boonen S, Barton IP, Dunlap LE, Burgio DE (2005) Safety and efficacy of risedronate in patients with age-related reduced renal function as estimated by the Cockcroft and Gault method: a pooled analysis of nine clinical trials. J Bone Miner Res 20:2105–2115PubMedCrossRefGoogle Scholar
  36. 36.
    Ishani A, Blackwell T, Jamal SA, Cummings SR, Ensrud KE (2008) The effect of raloxifene treatment in postmenopausal women with CKD. J Am Soc Nephrol 19:1430–1438PubMedCentralPubMedCrossRefGoogle Scholar
  37. 37.
    Miller PD, Schwartz EN, Chen P, Misurski DA, Krege JH (2007) Teriparatide in postmenopausal women with osteoporosis and mild or moderate renal impairment. Osteoporos Int 18:59–68PubMedCrossRefGoogle Scholar
  38. 38.
    Jamal SA, Ljunggren O, Stehman-Breen C, Cummings SR, McClung MR, Goemaere S, Ebeling PR, Franek E, Yang YC, Egbuna OI, Boonen S, Miller PD (2011) Effects of denosumab on fracture and bone mineral density by level of kidney function. J Bone Miner Res 26:1829–1835PubMedCrossRefGoogle Scholar

Copyright information

© International Osteoporosis Foundation and National Osteoporosis Foundation 2014

Authors and Affiliations

  • R. C. Bucur
    • 1
  • D. D. Panjwani
    • 1
  • L. Turner
    • 2
  • T. Rader
    • 3
  • S. L. West
    • 1
  • S. A. Jamal
    • 1
  1. 1.Women’s College Research InstituteTorontoCanada
  2. 2.Ottawa Hospital Research InstituteOttawaCanada
  3. 3.Cochrane Musculoskeletal Group, Centre for Global HealthUniversity of OttawaOttawaCanada

Personalised recommendations